<DOC>
	<DOCNO>NCT00002889</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure MRI may improve ability determine response prostate tumor therapy . PURPOSE : Phase II trial study MRI result patient prostate cancer treat radiation therapy plus androgen suppression therapy .</brief_summary>
	<brief_title>Radiation Therapy With Androgen Suppression Treating Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Establish whether change baseline 2-month post androgen suppression endorectal coil MRI result predict biochemical control follow radiotherapy androgen suppression patient adenocarcinoma prostate . OUTLINE : Patients undergo baseline endorectal coil MRI , follow total androgen suppression ( TAS ) either leuprolide IM subcutaneous goserelin month plus oral flutamide 3 time day 2 month . Patients receive second endorectal coil MRI , follow 2 month external-beam radiotherapy plus TAS . Patients may receive additional 2 month TAS discretion treat physician . Patients follow every 6 month 3 year , yearly thereafter . PROJECTED ACCRUAL : Approximately 180 patient ( approximately 60 per year ) accrue study 34 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Flutamide</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma prostate AJCC stage T1bT4b , N0 Nx , M0 Transrectal , transperineal , transurethral biopsy require PATIENT CHARACTERISTICS : Age : 30 Performance status : CALGB 02 Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : The following may increase risk protocol treatment : Serious intercurrent medical illness might compromise patient safety Active acute infection require antibiotic Suppression therapy chronic urinary tract infection allow Uncontrolled severe cardiovascular disease Psychiatric condition prevent compliance inform consent PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy carcinoma prostate Endocrine therapy : No prior androgen deprivation therapy ( medical surgical ) Radiotherapy : No prior radiation therapy carcinoma prostate Surgery : No prior surgical androgen deprivation therapy</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>